Approval · Notice of Compliance 21020 · 2018
YERVOY: Notice of Compliance 21020
Issued June 28, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21020
- Date
- June 28, 2018
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of commitment
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| YERVOY | Not yet assigned | — |
Medicinal ingredients
- IPILIMUMAB 5 MG per ML